Monitor future filings for any purchase order disclosures or recurring revenue updates from this account. The press release is a qualitative commercial milestone without quantifiable financial data — price action is likely muted until tangible revenue materializes.
Price Chart
Executive Summary
Microbot Medical announced its first Midwest account, a healthcare system in Michigan, for its LIBERTY Endovascular Robotic System. This follows a recent North Carolina adoption and expands the company's U.S. commercial footprint into a new region. The press release provides no financial details, customer name, or order quantities.
Key Facts
- Secured first Midwest-based account: a healthcare system in Michigan.
- LIBERTY Endovascular Robotic System is the first FDA-cleared single-use remotely operated robotic system for peripheral endovascular procedures.
- Company recently received regulatory approval from the Israeli Ministry of Health to market the system in Israel.
- U.S. peripheral endovascular procedure market is approximately 2.5 million procedures annually per the company.
- No financial terms, purchase quantities, or revenue impact were disclosed.
Financial Impact
No financial figures disclosed; customer identity, system pricing, order volume, and revenue contribution are not provided.
Risk Factors
- No revenue contribution from this account has been disclosed; near-term financial impact may be negligible.
- Commercial adoption of a novel robotic system in new hospital accounts carries implementation and utilization risks.
- Cash burn and dilution risks remain given the company's pre-revenue or early-revenue commercial stage status.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-027861 |
| Exhibit: ex99-1.htm | 0001493152-26-027861 |
| Document: 0001493152-26-027861-index-headers.html | 0001493152-26-027861 |
| Document: 0001493152-26-027861-index.html | 0001493152-26-027861 |
| Document: 0001493152-26-027861.txt | 0001493152-26-027861 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.9739 $0.9417 | ▼ −3.31% | ▼ −4.02% | $0.9700 (−0.40%) |
Oct 20, 2026 6d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | $0.9700 (+2.37%) |
Oct 6, 2026 20d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9700 (−9.35%) |
Oct 6, 2026 20d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9700 (−9.35%) |
Sep 28, 2026 28d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | $0.9700 (−22.40%) |
Aug 11, 2026 10w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | $0.9700 (−42.26%) |
Jul 21, 2026 13w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | $0.9700 (−46.11%) |
Jul 7, 2026 15w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | $0.9700 (−48.95%) |
Jun 30, 2026 16w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | $0.9700 (−50.26%) |
Jun 16, 2026 18w ago | 8-K | $1.82 $1.88 | ▲ +3.30% | ▲ +4.55% | $0.9700 (−46.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers